KANESA-THASAN NIRANJAN (Chief Medical Officer) sold 1.4% of their position (3.32K shares) of ICOSAVAX, INC. on the open market
Open‑market sale worth $29.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/1/2023ACC: 0001209191-23-044090
Officer· Chief Medical Officer
Since Jul 2021
-3.32K
Net shares
Net seller
$29.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.32K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.32K
Price / share
$8.86
Trade value
$29.45K
% of position
1.4%
7/31/2023
239.19K→235.86K
Total
Net shares
−3.32K
Net value
-$29.45K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/31/2023 | S · Sale | −3.32K | $8.86 | $29.45K | 1.4% | 239.19K | 235.86K |
| Total | −3.32K | -$29.45K | ||||||
Derivative Transactions0
No derivative transactions reported